Employees across the massive U.S. Health and Human Services Department began receiving notices of dismissal Tuesday in an ...

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

AstraZeneca’s Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Global Brain announced on the 5th that it has invested in Cala Health, a US-based developer and seller of wearable devices, through the KIRIN HEALTH INNOVATION FUND and Meiji Yasuda Future ...

Marks has long steered the FDA's regulation of vaccines as director of the Center for Biologics Evaluation and Research. He became especially well known during the first Trump administration for his ...

Kennedy Jr. In an email, an HHS official told CNN, “If Peter Marks does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA ...

Nicolette Shegstad is back on the Internal Revenue Service payroll but on administrative leave. Voyageurs National Park ...

The El Paso County Coroner's Office has identified the victim of a homicide in unincorporated Security-Widefield on Monday as 24-year-old Miguel Ramirez Quiroz, according to a release from the ...

“We are thrilled to receive FDA clearance for the AERO system, which represents the next evolution of our innovation pipeline,” said Trent Northcutt, President and CEO of Aurora Spine. “This system ...

Many of these relaxers are still sold in the U.S. Trump threatens to blow up Reeves’s Spring Statement days after it’s delivered Here's the Average Social Security Benefit at Ages 62, 67, and ...

FDA approved Johnson & Johnson’s Tremfya as the first IL-23 inhibitor with both SC and IV induction options for Crohn’s disease. Tremfya sales reached $3.67 billion in 2024, marking a 17% year ...